Evidence map›Paper›PMID 30316060›Full record

ArticleEuropean journal of medicinal chemistry2018

Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.

Shane M Hickey, Trent D Ashton, Gareth Boer, Christie A Bader, Michael Thomas, Alysha G Elliott, Carsten Schmuck, Heidi Y Yu, Jian Li, Roger L Nation and 4 more

Abstract read
In one paragraph

Article in European journal of medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Defining a lipophilicity window for the antimicrobial activity of 7-Alkoxy-3-Amino coumarin amphiphiles.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  2. SmIAngewandte Chemie (International ed. in English) · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Short Cationic Peptidomimetic Antimicrobials.Antibiotics (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Shane M HickeyCancer Research Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia. Electronic address: shane.hickey@unisa.edu.au.
Trent D AshtonThe Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, 3010, Australia.
Gareth BoerCentre for Chemistry and Biotechnology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, Victoria, 3216, Australia.
Christie A BaderCancer Research Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Michael ThomasResearch School of Chemistry, The Australian National University, Acton, ACT, 2601, Australia.
Alysha G ElliottInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, 4072, Australia.
Carsten SchmuckInstitute for Organic Chemistry, University of Duisburg-Essen, 45117, Essen, Germany.
Heidi Y YuDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Science, Royal Parade, Parkville, Victoria, 3052, Australia.
Jian LiDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Science, Royal Parade, Parkville, Victoria, 3052, Australia.
Roger L NationDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Science, Royal Parade, Parkville, Victoria, 3052, Australia.
Matthew A CooperInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, 4072, Australia.
Sally E PlushCancer Research Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Douglas A BrooksCancer Research Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, 5000, Australia.
Frederick M PfefferCentre for Chemistry and Biotechnology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, Victoria, 3216, Australia. Electronic address: fred.pfeffer@deakin.edu.au.
University of South Australia · AUDeakin University · AUThe University of Queensland · AUAustralian National University · AUThe University of Melbourne · AUUniversity of Duisburg-Essen · DE

Funding

Targeting superbugs: discovery and development of new broad-spectrum lipopeptidesR01AI098771 · NIAID · MONASH UNIVERSITY · PI LI, JIAN · 2012 to 2016
$4.3M
NIAID NIH HHS R01 AI098771Wellcome Trust
6 · The paper itself

Abstract

The design, synthesis and evaluation of a small series of potent amphiphilic norbornane antibacterial agents has been performed (compound 10 MIC = 0.25 μg/mL against MRSA). Molecular modelling indicates rapid aggregation of this class of antibacterial agent prior to membrane association and insertion. Two fluorescent analogues (compound 29 with 4-amino-naphthalimide and 34 with 4-nitrobenz-2-oxa-1,3-diazole fluorophores) with good activity (MIC = 0.5 μg/mL against MRSA) were also constructed and confocal microscopy studies indicate that the primary site of interaction for this family of compounds is the bacterial membrane.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesCell MembraneDose-Response Relationship, DrugMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsModels, MolecularMolecular StructureNorbornanesPeptidomimeticsStructure-Activity RelationshipAnti-Bacterial AgentsAntimicrobial Cationic PeptidesNorbornanesPeptidomimeticsAmphiphilicAntibacterialAntimicrobialFluorescenceNaphthalimideNorbornane and microscopy

Identifiers

PMID30316060
PMCPMC6309908
OpenAlexW2894594663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.